Symbol Name ID |
Del(5Cyp3a57-Cyp3a59)2Nki
deletion, Chr 5, The Netherlands Cancer Institute 2 MGI:3775603 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Cyp3a13tm1Nki/Cyp3a13tm1Nki Del(5Cyp3a57-Cyp3a59)2Nki/Del(5Cyp3a57-Cyp3a59)2Nki involves: 129P2/OlaHsd * FVB/N |
abnormal xenobiotic pharmacokinetics | J:127366 |
increased physiological sensitivity to xenobiotic | J:127366 | |
increased susceptibility to xenobiotic induced morbidity/mortality | J:127366 | |
Cyp3a13tm1Nki/Cyp3a13tm1Nki Del(5Cyp3a57-Cyp3a59)2Nki/Del(5Cyp3a57-Cyp3a59)2Nki Tg(APOE-CYP3A4)A1Nki/0 involves: 129P2/OlaHsd * FVB/N |
abnormal xenobiotic pharmacokinetics | J:127366 |
Cyp3a13tm1Nki/Cyp3a13tm1Nki Del(5Cyp3a57-Cyp3a59)2Nki/Del(5Cyp3a57-Cyp3a59)2Nki Tg(Vil1-CYP3A4)1Nki/0 involves: 129P2/OlaHsd * FVB/N |
abnormal xenobiotic pharmacokinetics | J:127366 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/19/2024 MGI 6.24 |
|
|